Cargando…

Long-acting or extended-release antiretroviral products for HIV treatment and prevention in infants, children, adolescents, and pregnant and breastfeeding women: knowledge gaps and research priorities

Antiretroviral agents with long-acting properties have potential to improve treatment outcomes substantially for people living with HIV. In November 2017, the Long acting/Extended Release Antiretroviral Resource Program (LEAP) convened a workshop with the aim of shaping the research agenda and promo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nachman, Sharon, Townsend, Claire L, Abrams, Elaine J, Archary, Moherndren, Capparelli, Edmund, Clayden, Polly, Lockman, Shahin, Jean-Philippe, Patrick, Mayer, Kenneth, Mirochnick, Mark, McKenzie-White, Jane, Struble, Kimberly, Watts, Heather, Flexner, Charles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152795/ https://www.ncbi.nlm.nih.gov/pubmed/31307946 http://dx.doi.org/10.1016/S2352-3018(19)30147-X

Ejemplares similares

Inclusion of pregnant women in antiretroviral drug research: what is needed to move forwards?
por: Fairlie, Lee, et al.
Publicado: (2019)

Pregnant and breastfeeding women: A priority population for HIV viral load monitoring
por: Myer, Landon, et al.
Publicado: (2017)

Importance of Prospective Studies in Pregnant and Breastfeeding Women Living With Human Immunodeficiency Virus
por: Colbers, Angela, et al.
Publicado: (2019)

Accelerating investigation of new HIV drugs in pregnancy: advancing the research agenda from theory to action
por: Penazzato, Martina, et al.
Publicado: (2022)

Optimizing Pharmacology Studies in Pregnant and Lactating Women Using Lessons From HIV: A Consensus Statement
por: Eke, Ahizechukwu C., et al.
Publicado: (2020)

The ADVANCE study: a groundbreaking trial to evaluate a candidate universal antiretroviral regimen
por: Venter, Willem D.F., et al.
Publicado: (2017)

Clinical and population‐based study design considerations to accelerate the investigation of new antiretrovirals during pregnancy
por: Brummel, Sean S., et al.
Publicado: (2022)

Engaging the community of women living with HIV to tailor and accelerate ARV research for pregnant and breastfeeding women
por: Clayden, Polly, et al.
Publicado: (2022)

Safety and Efficacy of Starting Antiretroviral Therapy in the First Week of Life
por: Maswabi, Kenneth, et al.
Publicado: (2020)

Characterization of Plasma Protein Alterations in Pregnant and Postpartum Individuals Living With HIV to Support Physiologically-Based Pharmacokinetic Model Development
por: Zhao, Sherry, et al.
Publicado: (2021)

Breastfeeding and the origins of health: Interdisciplinary perspectives and priorities
por: Azad, Meghan B., et al.
Publicado: (2020)

Approaches to accelerating the study of new antiretrovirals in pregnancy
por: Abrams, Elaine J., et al.
Publicado: (2022)

When could new antiretrovirals be recommended for national treatment programmes in low-income and middle-income countries: results of a WHO Think Tank
por: Vitoria, Marco, et al.
Publicado: (2017)

Phase 3 trials of new antiretrovirals are not representative of the global HIV epidemic
por: Pepperrell, Toby, et al.
Publicado: (2020)

HIV disease is associated with increased biomarkers of endothelial dysfunction despite viral suppression on long–term antiretroviral therapy in Botswana
por: Mosepele, Mosepele, et al.
Publicado: (2018)

Preferred antiretroviral drugs for the next decade of scale up
por: Andrieux-Meyer, Isabelle, et al.
Publicado: (2012)

Priorities for Decreasing Morbidity and Mortality in Children With Advanced HIV Disease
por: Frigati, Lisa, et al.
Publicado: (2018)

Global Pharmacovigilance for Antiretroviral Drugs: Overcoming Contrasting Priorities
por: Bakare, Nyasha, et al.
Publicado: (2011)

Antiretroviral postnatal prophylaxis to prevent HIV vertical transmission: present and future strategies
por: Penazzato, Martina, et al.
Publicado: (2023)

Hearing Loss in Offspring Exposed to Antiretrovirals During Pregnancy and Breastfeeding
por: DeBacker, J. Riley, et al.
Publicado: (2022)

Sexually transmitted infections in the era of antiretroviral-based HIV prevention: Priorities for discovery research, implementation science, and community involvement
por: Marrazzo, Jeanne M., et al.
Publicado: (2018)

Optimised paediatric antiretroviral treatment to achieve the 95-95-95 goals
por: Archary, Moherndran, et al.
Publicado: (2021)

Propelling the Pediatric HIV Therapeutic Agenda With Science, Innovation, and Collaboration
por: Abrams, Elaine J., et al.
Publicado: (2018)

Breastfeeding and the Developmental Origins of Asthma: Current Evidence, Possible Mechanisms, and Future Research Priorities
por: Miliku, Kozeta, et al.
Publicado: (2018)

Antiretroviral prophylaxis to prevent post-natal transmission of HIV through breastfeeding
por: Kuhn, Louise
Publicado: (2008)

Population Pharmacokinetics of Praziquantel in Pregnant and Lactating Filipino Women Infected with Schistosoma japonicum
por: Bustinduy, Amaya L., et al.
Publicado: (2020)

Physiologically‐based pharmacokinetic modeling of remdesivir and its metabolites in pregnant women with COVID‐19
por: Liu, Xiaomei I., et al.
Publicado: (2022)

Contribution of Maternal Antiretroviral Therapy and Breastfeeding to 24-Month Survival in Human Immunodeficiency Virus-Exposed Uninfected Children: An Individual Pooled Analysis of African and Asian Studies
por: Arikawa, Shino, et al.
Publicado: (2018)

Drug resistance after cessation of efavirenz-based antiretroviral treatment started in pregnancy
por: Ajibola, Globahan, et al.
Publicado: (2020)

Metabolic acidosis and encephalopathy in an HIV-exposed infant on breastfeeding and maternal antiretroviral therapy
por: Shah, Ira, et al.
Publicado: (2020)

Bugs, drugs, and HIV: the role of the vaginal microbiome in HIV risk and antiretroviral efficacy for HIV prevention
por: Liebenberg, Lenine J. P., et al.
Publicado: (2017)

Stakeholder engagement to identify priorities for improving the quality and value of care provided to critically ill patients
por: Stelfox, H, et al.
Publicado: (2015)

Triple-Antiretroviral Prophylaxis to Prevent Mother-To-Child HIV Transmission through Breastfeeding—The Kisumu Breastfeeding Study, Kenya: A Clinical Trial
por: Thomas, Timothy K., et al.
Publicado: (2011)

Breastfeeding and Later‐Life Cardiometabolic Health in Women With and Without Hypertensive Disorders of Pregnancy
por: Magnus, Maria C., et al.
Publicado: (2023)

Pharmacogenomics of drug transporters for antiretroviral long-acting pre-exposure prophylaxis for HIV
por: Zondo, Nomusa M., et al.
Publicado: (2022)

Breastfeeding support at an Australian Breastfeeding Association drop-in service: a descriptive survey
por: Burns, Elaine S., et al.
Publicado: (2020)

From Pediatric Covariate Model to Semiphysiological Function for Maturation: Part I–Extrapolation of a Covariate Model From Morphine to Zidovudine
por: Krekels, E H J, et al.
Publicado: (2012)

Co-Morbidity, Ageing and Predicted Mortality in Antiretroviral Treated Australian Men: A Quantitative Analysis
por: Furuya-Kanamori, Luis, et al.
Publicado: (2013)

The only way is up: priorities for implementing long-acting antiretrovirals for HIV prevention and treatment
por: Castor, Delivette, et al.
Publicado: (2020)

Barriers to adherence to antiretroviral therapy: identifying priority areas for people with HIV and healthcare professionals
por: Mate, Kedar K. V., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mur8kberjolusijbb3cdnaefip